Therapeutic Strategies Targeting CD163 and CD169 in Macrophages for Cancer
Authors:
- 12 November 2025
- journal article
- review article
- Published by Wiley in Pathology International
- Vol. 75 (11) , 551-561
Abstract
Macrophage activation markers, specifically CD163 and CD169, play pivotal roles in the modulation of immune responses within the tumor microenvironment (TME), influencing the outcome of various cancers. These markers delineate the activation states of macrophages, with CD163 associated with the protumoral phenotype and CD169 with activation of tumor immunity. This review comprehensively explores the dualistic roles of these markers in cancer progression and immune suppression, and discusses the mechanisms through which these markers influence macrophage behavior, the impact of their expression on cancer progression, and the therapeutic potential of targeting these pathways to reprogram the TME toward enhancing antitumor immunity. This review aims to underscore the therapeutic potential of macrophage activation markers as targets for cancer treatment, highlighting emerging strategies and future directions in cancer immunotherapy.Keywords
This publication has 46 references indexed in Scilit:
- Cyclic sulfur compounds targeting macrophage polarization into M2/protumor phenotype and their anti-tumor effectsCancer Immunology, Immunotherapy, 2021
- Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor α In Endometrial CancerCell Reports, 2018
- Functional CD169 on Macrophages Mediates Interaction with Dendritic Cells for CD8+ T Cell Cross-PrimingCell Reports, 2018
- Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progressionCancer Immunology, Immunotherapy, 2017
- Onionin A, a sulfur‐containing compound isolated from onions, impairs tumor development and lung metastasis by inhibiting the protumoral and immunosuppressive functions of myeloid cellsMolecular Nutrition & Food Research, 2016
- Macrophage Activation and Polarization: Nomenclature and Experimental GuidelinesImmunity, 2014
- Corosolic acid impairs tumor development and lung metastasis by inhibiting the immunosuppressive activity of myeloid‐derived suppressor cellsMolecular Nutrition & Food Research, 2013
- CD169-Positive Macrophages Dominate Antitumor Immunity by Crosspresenting Dead Cell-Associated AntigensImmunity, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Possible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomasThe Journal of Pathology, 2008